Child Neurology Foundation Announces Ambry Genetics as Champion Level Partner

Partnership expands CNF education initiatives, diagnostics access, and resources for families & healthcare professionals across pediatric onset neurologic care

Ambry Genetics (NASDAQ:TEM)

LEXINGTON, KY, UNITED STATES, March 11, 2026 /EINPresswire.com/ -- The Child Neurology Foundation (CNF) today announced Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), as a Champion Level Partner, supporting CNF’s education initiatives and critical resources for families and healthcare professionals across the child neurology community.

3DR Labs Redefines Imaging Operations with Strings First-of-Its-Kind Intent-Driven Agentic AI

Intent Driven Autonomous Intelligence

Strings’ Agentic AI predicts clinical intent to accelerate workflow, minimize manual tasks, and lower healthcare costs.

LOUISVILLE, KY, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- 3DR® Labs, together with its wholly owned subsidiary Strings, today announced the release of a groundbreaking Agentic AI capability within

Beyond-Sleep Encourages Everyone to Sleep Better, Live Well on World Sleep Day

Make a Plan to Prioritize your Sleep Health with the Beyond-Sleep VibraSonic Sleep System

Make a plan to prioritize your sleep health with our Beyond-Sleep Vibrasonic Sleep System to elevate your sleep experience beyond the ordinary.”

— Robert Eskridge, executive deputy manager of Beyond-Sleep

LEXINGTON, KY, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Beyond-Sleep is encouraging everyone to make sleep health a priority on World Sleep Day, Friday, March 13, 2026.

The Beyond-Sleep VibraSonic Sleep System is the first of its kind immersive sleep system,